Portfolio Update

RNS Number : 8214O

Intl. Biotechnology Trust PLC

23 August 2017

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 31 July 2017

Net Assets	£244m
Net Assets per share	650p
Share price	624p
Total value of unquoted investments	£22m
Total number of portfolio companies	91
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Celgene	7.6
Regeneron	6.6
Biogen	5.4
Genmab	5.0
Vertex	4.3
Gilead	3.9
Alexion	3.7
Biomarin	3.2
Incyte	3.2
Amgen	2.8
	-----------
Total	45.7

Geographical Allocation	% NAV
US & Canada	83
Europe & UK	17
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	91
Unquoted	9
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	50
Mid Cap =USD1-10BN	27
Small Cap <USD1BN	23
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	37
Rare diseases	14
Ophthalmology	9
CNS	9
Inflammation	6
Medtech	2
Other	23
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

23 AUGUST 2017

 

END

 

 

PFUBUGDIDDDBGRX